Pipeline

Beclomethasone 17,21-dipropionate (BDP) is a highly potent, topically active corticosteroid with a local effect on inflamed tissue. BDP has been marketed in the U.S. and worldwide since the early 1970s as the active pharmaceutical ingredient in a nasal spray and in a metered-dose inhaler for the treatment of allergic rhinitis and asthma in both adults and children. The rationale for its administration is that it provides a potent topical anti-inflammatory effect with less systemic toxicity than a comparably effective systemic corticosteroid. 

Soligenix has several proprietary products designed to take advantage of the topical activity of BDP for the treatment of gastrointestinal inflammation: orBec^®, SGX201, and SGX203.